Experiences and Treatment Preferences in Patients With Psoriatic Arthritis: A Cross-Sectional Study in the ArthritisPower Registry

被引:0
作者
Alexis Ogdie
Kelley Myers
Carol Mansfield
William Tillett
Peter Nash
Colton Leach
W. Benjamin Nowell
Kelly Gavigan
Patrick Zueger
Erin McDearmon-Blondell
Jessica Walsh
机构
[1] University of Pennsylvania,Division of Rheumatology, Perelman School of Medicine
[2] RTI Health Solutions,Department of Rheumatology
[3] Royal National Hospital for Rheumatic Diseases,Department of Pharmacy and Pharmacology
[4] University of Bath,Department of Medicine
[5] Griffith University,Division of Rheumatology
[6] Global Healthy Living Foundation,undefined
[7] AbbVie Inc.,undefined
[8] University of Utah School of Medicine,undefined
来源
Rheumatology and Therapy | 2022年 / 9卷
关键词
Best–worst scaling; Disease impacts; Joint pain; Patient preferences; Psoriatic arthritis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:735 / 751
页数:16
相关论文
共 184 条
[1]  
Alinaghi F(2019)Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies J Am Acad Dermatol 80 251-65 e19
[2]  
Calov M(2010)Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis J Autoimmun 34 J314-J321
[3]  
Kristensen LE(2014)Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey J Am Acad Dermatol 70 871-881 e1–30
[4]  
Gladman DD(2017)The changing face of clinical trials in psoriatic arthritis Curr Rheumatol Rep 19 21-462
[5]  
Coates LC(2017)Important treatment outcomes for patients with psoriatic arthritis: a multisite qualitative study Patient 10 455-637
[6]  
Jullien D(2020)Disease characteristics and the burden of joint and skin involvement amongst people with psoriatic arthritis: a population survey Rheumatol Ther 7 617-1071
[7]  
Chandran V(2016)Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis Arthritis Rheumatol 68 1060-510
[8]  
Raychaudhuri SP(2016)European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update Ann Rheum Dis 75 499-32
[9]  
Lebwohl MG(2019)Special article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis Arthritis Rheumatol 71 5-401
[10]  
Bachelez H(2006)Rheumatology care: involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitis Arthritis Rheum 55 394-56